Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)

Wijma S, de Boer JE
Record ID 32018001626
Original Title: Package advice for ibrutinib (Imbruvica®)
Project Status: Completed
Year Published: 2020
English language abstract: An English language summary is available
Publication Type: Other
Country: The Netherlands
MeSH Terms
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Anti-Infective Agents
  • Pyrazoles
  • Pyrimidines
  • Long Term Adverse Effects
Organisation Name: The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address: Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name: Timon Sibma
Contact Email: TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.